Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Michelle Mancher"'
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Medication-Assisted Treatment for Opioid Use Disorder, Michelle Mancher, Alan I. Leshner
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are es
Autor:
Institute of Medicine, Board on Health Care Services, Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care, Ashna Kibria, Michelle Mancher, Margaret A. McCoy, Robin P. Graham, Alan M. Garber, Joseph P. Newhouse
Interim Report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Health Care: Preliminary Committee Observations is designed to provide the committee's preliminary observations for the 113th Congress as it c
Autor:
Alan I. Leshner, Michelle Mancher
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcf64a75dcfeda8de5aedace882f35a9
https://doi.org/10.17226/25310
https://doi.org/10.17226/25310
When is it appropriate to return individual research results to participants? The immense interest in this question has been fostered by the growing movement toward greater transparency and participant engagement in the research enterprise. Yet, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42ede9a32e5f6540d06166d4a61a39f4
https://doi.org/10.17226/25094
https://doi.org/10.17226/25094
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on the Return of Individual-Specific Research Results Generated in Research Laboratories, Autumn S. Downey, Emily R. Busta, Michelle Mancher, Jeffrey R. Botkin
When is it appropriate to return individual research results to participants? The immense interest in this question has been fostered by the growing movement toward greater transparency and participant engagement in the research enterprise. Yet, the
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Board on Global Health, Committee on Clinical Trials During the 2014-2015 Ebola Outbreak, Emily R. Busta, Michelle Mancher, Patricia A. Cuff, Keith McAdam, Gerald Keusch
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate
Publikováno v:
Integrating Clinical Research into Epidemic Response: The Ebola Experience
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c558da8e5b60f8e9baaec73db877128
https://doi.org/10.17226/24739
https://doi.org/10.17226/24739
Publikováno v:
Global Health Risk Framework: Research and Development of Medical Products: Workshop Summary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e92867959237de308f8a8ef6612a563d
https://doi.org/10.17226/21853
https://doi.org/10.17226/21853
Autor:
Institute of Medicine, Board on Health Care Services, Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care, Ashna Kibria, Michelle Mancher, Margaret A. McCoy, Robin P. Graham, Alan M. Garber, Joseph P. Newhouse
Health care in the United States is more expensive than in other developed countries, costing $2.7 trillion in 2011, or 17.9 percent of the national gross domestic product. Increasing costs strain budgets at all levels of government and threaten the
Autor:
Institute of Medicine, Board on Health Care Services, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Earl Steinberg, Sheldon Greenfield, Dianne Miller Wolman, Michelle Mancher, Robin Graham
Advances in medical, biomedical and health services research have reduced the level of uncertainty in clinical practice. Clinical practice guidelines (CPGs) complement this progress by establishing standards of care backed by strong scientific eviden